What is IG Therapy?
IG therapy is a subcutaneous immunoglobulin system meant to treat Primary Immunodeficiency. The development of our system pioneered subcutaneous administration of immunoglobulin.
What is EMED's role?
EMED designs and develops medical devices and works closely with pharmacies and distributors to provide access to a superior infusion system. EMED has been at the forefront of IG Therapy since its inception and continues to explore and develop technologies for various therapies to improve patients' lives and infusion experience.
What sets us apart?
As a patient-centric company, EMED is focused on developing products to serve patients every step of the way.
EMED invests financial and human capital to be at the forefront of research to continuously improve infusion technology.
As proven by independent testing, EMED provides the highest standards of infusion experience in the industry.